Advertisements


Alnylam says Onpattro to be available from two specialty pharmacies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Birmingham firm lands specialty pharmacy contract with Massachusetts hospital

The contract is for a specialty pharmacy, which operate under much stricter guidelines than retail pharmacies, according to its leadership......»»

Category: topSource: bizjournalsApr 11th, 2024

Alnylam cuts FY20 ONPATTRO revenue view to $270M-$300M from $285M-$315M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 6th, 2020

Alnylam an Gen sign distribution agreement for Onpattro in Turkey

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 25th, 2020

Hunstman to make 50 tons of hand sanitizer, and give them to hospitals and pharmacies

Specialty chemicals company Huntsman Corp. said Monday it will start making hydro alcoholic solution to produce hand sanitizers at its Monthey, Switzerland manufacturing site. The.....»»

Category: topSource: marketwatchMar 23rd, 2020

Major national retailer to buy Schnucks" pharmacies, 11 of 110 to close

CVS on Tuesday said it is buying Schnuck Markets' retail and specialty pharmacy businesses. Terms weren't disclosed. The retailer, through its CVS Pharmacy and other subsidiaries, said it would acquire and operate 99 of the grocer's pharmacies and bra.....»»

Category: topSource: bizjournalsMar 10th, 2020

Alnylam announces ANVISA approval of Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 26th, 2020

Alnylam reports preliminary Q4 global net product revenues of $56M for ONPATTRO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 12th, 2020

Alnylam presented results from Apollo Phase 3 study of Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 3rd, 2019

Alnylam Presents New Data for RNAi Therapeutic Onpattro

Zacks.....»»

Category: topSource: redinewsJun 25th, 2019

Alnylam presents new ONPATTRO results at 2019 PNS meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2019

Alnylam announces approval for Onpattro in Japan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2019

Alnylam Posts Another Encouraging Quarter Early In Onpattro"s Launch

Alnylam Posts Another Encouraging Quarter Early In Onpattro"s Launch.....»»

Category: topSource: seekingalphaMay 2nd, 2019

FDA approves Alnylam"s Onpattro as hATTR treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam"s Onpattro approved by FDA to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam confirms FDA approves Onpattro to treat polyneuropathy caused by hATTR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam tells Bloomberg will work with FDA to get broader claims for Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam announces alignment on value-based agreements for Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam sees annual average list price before discounts of Onpattro of $450,000

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam expects Germany to be first EU launch country for Onpattro

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Alnylam rare drug gets FDA approval, to cost $345,000 on oaverage

Alnylam Pharmaceuticals Inc.'s rare disease drug Onpattro has been approved by the Food and Drug Administration, marking the first approval of a therapy that employs the RNA interference (RNAi) gene-silencing technique. Onpattro, also called patis.....»»

Category: topSource: marketwatchAug 10th, 2018